115 related articles for article (PubMed ID: 34060447)
1. [G6PC knockdown blocks AKT/mTOR pathway to inhibit proliferation, invasion and migration of cervical cancer HeLa cells].
Deng C; Zhu K; Liu T; Chen L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jun; 37(6):520-526. PubMed ID: 34060447
[TBL] [Abstract][Full Text] [Related]
2. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.
Zhu K; Deng C; Du P; Liu T; Piao J; Piao Y; Yang M; Chen L
Reprod Biol Endocrinol; 2022 Mar; 20(1):50. PubMed ID: 35277194
[TBL] [Abstract][Full Text] [Related]
3. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
Teng P; Jiao Y; Hao M; Tang X
J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
Li YM; Li XJ; Yang HL; Zhang YB; Li JC
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
6. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human cervical cancer cell growth by Salviolone is mediated via autophagy induction, cell migration and cell invasion suppression, G2/M cell cycle arrest and downregulation of Nf-kB/m-TOR/PI3K/AKT pathway.
Zhang Y; Li G; Ji C
J BUON; 2018; 23(6):1739-1744. PubMed ID: 30610802
[TBL] [Abstract][Full Text] [Related]
8. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
9. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
[TBL] [Abstract][Full Text] [Related]
10. LncRNA GHET1 promotes cervical cancer progression through regulating AKT/mTOR and Wnt/β-catenin signaling pathways.
Liu Z; Luo S; Wu M; Huang C; Shi H; Song X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31682716
[TBL] [Abstract][Full Text] [Related]
11. SRSF3 Restriction Eases Cervical Cancer Cell Viability and Metastasis via Adjusting PI3K/AKT/mTOR Signaling Pathway.
Zhang L; Li J; Zhang L
Contrast Media Mol Imaging; 2022; 2022():8497078. PubMed ID: 36237584
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
13. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
14. [Polydatin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling pathway].
Pan JH; Wang HB; Du XF; Liu JY; Zhang DJ
Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2345-2349. PubMed ID: 28822191
[TBL] [Abstract][Full Text] [Related]
15. NCAM regulates the proliferation, apoptosis, autophagy, EMT, and migration of human melanoma cells via the Src/Akt/mTOR/cofilin signaling pathway.
Li J; Yang R; Yang H; Chen S; Wang L; Li M; Yang S; Feng Z; Bi J
J Cell Biochem; 2020 Feb; 121(2):1192-1204. PubMed ID: 31468584
[TBL] [Abstract][Full Text] [Related]
16. LDLRAD2 promotes pancreatic cancer progression through Akt/mTOR signaling pathway.
Li J; Huang W; Han Q; Xiong J; Song Z
Med Oncol; 2021 Jan; 38(1):2. PubMed ID: 33392788
[TBL] [Abstract][Full Text] [Related]
17. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA OGFRP1 Inhibits Proliferation and Invasion of JEG-3 Cells Via AKT/mTOR Pathway.
Meng Q; Xue H
Technol Cancer Res Treat; 2020; 19():1533033820905823. PubMed ID: 32233835
[TBL] [Abstract][Full Text] [Related]
19. CDKN2A inhibits cell proliferation and invasion in cervical cancer through LDHA-mediated AKT/mTOR pathway.
Luan Y; Zhang W; Xie J; Mao J
Clin Transl Oncol; 2021 Feb; 23(2):222-228. PubMed ID: 32594303
[TBL] [Abstract][Full Text] [Related]
20. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]